Overview
Ovarian cancer is often diagnosed at an advanced stage because early symptoms are vague. Modern treatment combines surgery with platinum-based chemotherapy and — for many patients — PARP inhibitor maintenance therapy to prolong remission.
Dr. Ravi Jaiswal tests every patient for BRCA and HRD status to identify those who benefit most from PARP inhibitors like olaparib or niraparib.
Symptoms to watch for
- Persistent bloating or abdominal distension
- Pelvic or abdominal pain
- Feeling full quickly when eating
- Frequent or urgent urination
- Change in bowel habits
How we treat it
- Carboplatin + paclitaxel chemotherapy
- Bevacizumab in high-risk patients
- PARP inhibitor maintenance (olaparib, niraparib)
- BRCA and HRD genetic testing
- Chemotherapy for platinum-resistant disease
Frequently asked questions
Should I get tested for BRCA?+
Yes — every woman with ovarian cancer should have germline BRCA testing. It affects both treatment choice and family screening.
What is PARP inhibitor maintenance?+
It's an oral pill taken after chemotherapy to prevent recurrence. In BRCA-positive patients, it can extend remission by years.
This page is for information only and does not replace a medical consultation. Please speak to a qualified doctor for advice specific to your condition.